NASDAQ:AKTX
$0.500
(
-1.96%
)
Friday, 27th Jan 2023
Akari Therapeutics Plc Stock Price (Quote)
| Range | Low Price | High Price | Comment |
|---|---|---|---|
| 30 days | $0.380 | $0.550 | Friday, 27th Jan 2023 AKTX stock ended at $0.500. This is 1.96% less than the trading day before Thursday, 26th Jan 2023. During the day the stock fluctuated 17.78% from a day low at $0.450 to a day high of $0.530. |
| 90 days | $0.380 | $0.627 | |
| 52 weeks | $0.380 | $1.61 |
Historical Akari Therapeutics Plc prices
| Date | Open | High | Low | Close | Volume |
| 2023-01-27 | $0.500 | $0.530 | $0.450 | $0.500 | 128 780 |
| 2023-01-26 | $0.530 | $0.540 | $0.473 | $0.510 | 50 969 |
| 2023-01-25 | $0.510 | $0.540 | $0.510 | $0.519 | 81 853 |
| 2023-01-24 | $0.500 | $0.520 | $0.450 | $0.495 | 205 168 |
| 2023-01-23 | $0.520 | $0.520 | $0.452 | $0.491 | 62 636 |
| 2023-01-20 | $0.500 | $0.540 | $0.460 | $0.500 | 140 158 |
| 2023-01-19 | $0.500 | $0.510 | $0.500 | $0.510 | 4 800 |
| 2023-01-18 | $0.510 | $0.510 | $0.475 | $0.490 | 22 927 |
| 2023-01-17 | $0.500 | $0.530 | $0.490 | $0.501 | 28 014 |
| 2023-01-13 | $0.500 | $0.540 | $0.480 | $0.540 | 8 351 |
| 2023-01-12 | $0.500 | $0.540 | $0.465 | $0.540 | 42 400 |
| 2023-01-11 | $0.510 | $0.540 | $0.440 | $0.540 | 58 000 |
| 2023-01-10 | $0.537 | $0.540 | $0.489 | $0.499 | 43 315 |
| 2023-01-09 | $0.520 | $0.550 | $0.510 | $0.531 | 111 009 |
| 2023-01-06 | $0.517 | $0.530 | $0.480 | $0.525 | 74 738 |
| 2023-01-05 | $0.520 | $0.520 | $0.500 | $0.510 | 57 044 |
| 2023-01-04 | $0.450 | $0.520 | $0.450 | $0.519 | 50 720 |
| 2023-01-03 | $0.443 | $0.515 | $0.380 | $0.493 | 60 649 |
| 2022-12-30 | $0.440 | $0.500 | $0.440 | $0.470 | 167 482 |
| 2022-12-29 | $0.427 | $0.470 | $0.427 | $0.440 | 39 234 |
| 2022-12-28 | $0.410 | $0.500 | $0.400 | $0.450 | 142 932 |
| 2022-12-27 | $0.452 | $0.452 | $0.400 | $0.440 | 88 016 |
| 2022-12-23 | $0.410 | $0.490 | $0.410 | $0.450 | 49 502 |
| 2022-12-22 | $0.486 | $0.486 | $0.435 | $0.454 | 56 783 |
| 2022-12-21 | $0.504 | $0.550 | $0.470 | $0.490 | 33 127 |
| 2022-12-20 | $0.431 | $0.496 | $0.431 | $0.440 | 89 060 |
| 2022-12-19 | $0.450 | $0.450 | $0.400 | $0.410 | 188 324 |
| 2022-12-16 | $0.510 | $0.510 | $0.440 | $0.449 | 59 787 |
| 2022-12-15 | $0.455 | $0.540 | $0.455 | $0.460 | 15 660 |
| 2022-12-14 | $0.509 | $0.540 | $0.440 | $0.481 | 117 761 |
| 2022-12-13 | $0.530 | $0.548 | $0.520 | $0.520 | 6 482 |
| 2022-12-12 | $0.570 | $0.570 | $0.500 | $0.522 | 21 910 |
| 2022-12-09 | $0.531 | $0.572 | $0.514 | $0.526 | 46 737 |
| 2022-12-08 | $0.540 | $0.550 | $0.501 | $0.530 | 45 539 |
| 2022-12-07 | $0.574 | $0.574 | $0.540 | $0.570 | 53 678 |
| 2022-12-06 | $0.540 | $0.600 | $0.500 | $0.540 | 18 537 |
| 2022-12-05 | $0.575 | $0.600 | $0.550 | $0.559 | 101 252 |
| 2022-12-02 | $0.500 | $0.550 | $0.500 | $0.539 | 49 705 |
| 2022-12-01 | $0.550 | $0.555 | $0.500 | $0.530 | 141 770 |
| 2022-11-30 | $0.540 | $0.555 | $0.540 | $0.553 | 76 407 |
| 2022-11-29 | $0.585 | $0.587 | $0.475 | $0.540 | 53 705 |
| 2022-11-28 | $0.578 | $0.590 | $0.570 | $0.580 | 129 923 |
| 2022-11-25 | $0.542 | $0.577 | $0.500 | $0.567 | 21 084 |
| 2022-11-23 | $0.565 | $0.573 | $0.551 | $0.573 | 26 508 |
| 2022-11-22 | $0.560 | $0.587 | $0.540 | $0.566 | 22 014 |
| 2022-11-21 | $0.599 | $0.618 | $0.569 | $0.618 | 40 572 |
| 2022-11-18 | $0.585 | $0.616 | $0.551 | $0.599 | 50 800 |
| 2022-11-17 | $0.585 | $0.590 | $0.572 | $0.572 | 12 815 |
| 2022-11-16 | $0.546 | $0.600 | $0.546 | $0.583 | 23 129 |
| 2022-11-15 | $0.600 | $0.610 | $0.566 | $0.570 | 54 234 |
About Akari Therapeutics Plc
Akari Therapeutics, Plc, a clinical-stage biopharmaceutical company, focuses on developing advanced therapies for autoimmune and inflammatory diseases. Its lead product candidate is nomacopan, a second-generation complement inhibitor that prevents inflammatory and prothrombotic activities, including paroxysmal nocturnal hemoglobinuria, Guillain-Barré syndrome, hematopoietic stem cell transplant-associated thrombotic microangiopathy, and bullous ... AKTX Profile
Top Fintech Company
featured in The Global Fintech Index 2020 as the top Fintech company of the country.
